Purchase Order HT001415P1966
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to The Harvard Drug Group, L.L.C. (The Harvard Drug Group), a subsidiary of Cardinal Health, Inc. The $22,590.14 firm-fixed-price contract is for the supply of other medical products, with an ultimate completion date of January 3, 2023. The Harvard Drug Group is a leading provider of pharmaceutical products and medical supplies to the U.S. military, Department of Veterans Affairs, and other government...
- The Defense Logistics Agency Troop Support Medical awarded a $23,577.96 firm fixed price delivery order to The Harvard Drug Group, L.L.C. for other medical products. The Harvard Drug Group will deliver the products to Livonia, Michigan by January 31, 2022 in performance of contract number 8507817288. As a pharmaceutical manufacturer and distributor, The Harvard Drug Group provides generic prescription and over-the-counter drugs and medical supplies to U.S. government agencies through its Major...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract worth $1,656.00 to The Harvard Drug Group, L.L.C., a subsidiary of Cardinal Health, Inc. The contract is for the delivery of 4563455503 ! MUCUS RLF DM ER 600-30 MG TAB 20S, a pharmaceutical product, to be completed by January 31, 2024. The Harvard Drug Group, L.L.C. is a leading provider of pharmaceutical products and medical supplies to the U.S. military, Department of Veterans Affairs, and...
- The Harvard Drug Group, L.L.C., a Native Hawaiian Organization-owned pharmaceutical distributor and subsidiary of Cardinal Health, Inc., was awarded a delivery order contract by the Defense Logistics Agency's Medical Supply Chain on October 8, 2025, for the supply of acetaminophen 500 mg tablets in quantities of 1,000 units. This firm fixed-price delivery order carries a ceiling value of $1,136.52 and is scheduled for ultimate completion by October 9, 2025. The contract utilizes no small...
- The Harvard Drug Group, L.L.C., a Native Hawaiian Organization-owned subsidiary of Cardinal Health, Inc., was awarded a delivery order contract by the Defense Logistics Agency's Medical Supply Chain on February 2, 2026, for the procurement of Acetaminophen 500 mg tablets in quantities of 1,000 units. This firm fixed-price delivery order carries a ceiling value of $1,298.88 with an ultimate completion date of February 3, 2026. The contract was awarded without a small business set-aside...
- This federal contract award is for the delivery of pharmaceutical and medical supplies, including prescription medications, over-the-counter drugs, vaccines, radiopharmaceuticals, and other medical consumables, under the Defense Logistics Agency's (DLA) Pharmaceutical Prime Vendor program. The prime contractor is Cardinal Health, Inc., a global healthcare services and products company that has a long-standing relationship with the U.S. federal government, particularly the Department of Defense...
- The federal contract award is for the supply of pharmaceutical and medical products to the U.S. government. The prime contractor is Cardinal Health, Inc., a global healthcare services and products company with extensive experience in government contracting. This $89,107.76 firm fixed-price delivery order contract was awarded by the Defense Logistics Agency's (DLA) Medical Supply Chain program on May 7, 2015, with a completion date of May 8, 2015. The contract is for the TRICARE West program...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a large for-profit healthcare services company. The award, with a ceiling value of $121,308.02, is for the delivery of pharmaceutical products to support the DLA's Pharmaceutical Prime Vendor program. This program provides a comprehensive range of medical supplies, including prescription medications, vaccines, and other consumables, to military treatment facilities and deployed troops worldwide....
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a major pharmaceutical and medical supplies distributor, under the DLA's Pharmaceutical Prime Vendor program. The contract, valued at $83,770.97, is for the provision of a range of pharmaceutical products, including antibiotics, pain medications, vaccines, and specialty drugs, to military treatment facilities and deployed troops worldwide. Cardinal Health has a long-standing...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a $250,744.50 firm fixed-price delivery order contract to Cardinal Health, Inc. for pharmaceutical distribution services under the Pharmaceutical Prime Vendor program. The contract, which has no set-aside designation, has an ultimate completion date of August 14, 2024. Cardinal Health, a global healthcare services and products company, has a long history of providing pharmaceutical and medical supplies to various...
This federal contract award was issued by the Defense Health Agency (DHA) to The Harvard Drug Group, L.L.C., a subsidiary of Cardinal Health, Inc. The $7,427.00 firm-fixed-price purchase order is for the supply of 3-port TOPI-CLICK pink medication dispensers (250 count). The award has no set-aside designation, indicating The Harvard Drug Group's ability to compete in unrestricted federal procurements. The Harvard Drug Group is a major pharmaceutical manufacturer and distributor that has a substantial Indefinite Delivery Contract (IDV) worth up to $62.9 million with the Department of Veterans Affairs (VA) National Acquisition Center. This single-award IDV, running through October 2023 with potential extensions, covers the supply of tamsulosin hydrochloride capsules to multiple federal agencies, including the VA, Department of Defense, Bureau of Prisons, and Indian Health Service, through their respective pharmaceutical prime vendor programs. This contract award demonstrates The Harvard Drug Group's capacity to secure and manage large-scale, multi-agency pharmaceutical supply agreements, solidifying its position as a key player in the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.4k | 9/23/15 |